Correlation Between Biomarin Pharmaceutical and MannKind Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and MannKind Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and MannKind Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and MannKind Corp, you can compare the effects of market volatilities on Biomarin Pharmaceutical and MannKind Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of MannKind Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and MannKind Corp.

Diversification Opportunities for Biomarin Pharmaceutical and MannKind Corp

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Biomarin and MannKind is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and MannKind Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MannKind Corp and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with MannKind Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MannKind Corp has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and MannKind Corp go up and down completely randomly.

Pair Corralation between Biomarin Pharmaceutical and MannKind Corp

Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the MannKind Corp. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 1.38 times less risky than MannKind Corp. The stock trades about -0.06 of its potential returns per unit of risk. The MannKind Corp is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  334.00  in MannKind Corp on August 28, 2024 and sell it today you would earn a total of  338.00  from holding MannKind Corp or generate 101.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biomarin Pharmaceutical  vs.  MannKind Corp

 Performance 
       Timeline  
Biomarin Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomarin Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
MannKind Corp 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MannKind Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward-looking signals, MannKind Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.

Biomarin Pharmaceutical and MannKind Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomarin Pharmaceutical and MannKind Corp

The main advantage of trading using opposite Biomarin Pharmaceutical and MannKind Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, MannKind Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MannKind Corp will offset losses from the drop in MannKind Corp's long position.
The idea behind Biomarin Pharmaceutical and MannKind Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Managers
Screen money managers from public funds and ETFs managed around the world